aflatoxin b1 has been researched along with rotenone in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Castell, JV; Donato, MT; Gómez-Lechón, MJ; Pérez-Cataldo, G; Tolosa, L | 1 |
| Carpi, D; Lloyd, GR; Malinowska, JM; Palosaari, T; Sund, J; Viant, MR; Weber, RJM; Whelan, M | 1 |
4 other study(ies) available for aflatoxin b1 and rotenone
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Upgrading cytochrome P450 activity in HepG2 cells co-transfected with adenoviral vectors for drug hepatotoxicity assessment.
Topics: Adenoviridae; Aflatoxin B1; Aryl Hydrocarbon Hydroxylases; Calcium; Cell Survival; Chemical and Drug Induced Liver Injury; Citric Acid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Genetic Vectors; Hep G2 Cells; Humans; Membrane Potential, Mitochondrial; Models, Biological; Rotenone; Transfection | 2012 |
Derivation of metabolic point of departure using high-throughput in vitro metabolomics: investigating the importance of sampling time points on benchmark concentration values in the HepaRG cell line.
Topics: Aflatoxin B1; Benchmarking; Benzo(a)pyrene; Cell Line; Cyclosporine; Lipids; Metabolomics; Rotenone | 2023 |